Christine Siu

Insider Reports History

Entity
Individual
Location
C/O Eidos Therapeutics, Inc., 101 Montgomery Street, Suite 2550, San Francisco, CA
Signature
/s/ Markus Warmuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christine Siu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. Director Stock Option (Right to Buy) 22.1K Jun 12, 2024 Direct

Insider Reports Filed by Christine Siu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GLUE Monte Rosa Therapeutics, Inc. Jun 12, 2024 1 $0 4 Jun 13, 2024 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 Director
GLUE Monte Rosa Therapeutics, Inc. Apr 12, 2021 2 $0 4 Jun 25, 2021 Director